{
    "Overall_score": {
        "Correlation": 9,
        "Sentiment": 7,
        "Importance": 8,
        "Impact": 7,
        "Duration": 6,
        "Virality": 4,
        "Source_Score": 8,
        "Specificity": 9,
        "Sector_Spread": 5,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "Celgene (CELG) Earnings Report: Q4 2015 Conference Call",
            "Correlation": 10,
            "Sentiment": 8,
            "Importance": 9,
            "Impact": 8,
            "Duration": 7,
            "Virality": 5,
            "Source_Score": 9,
            "Specificity": 10,
            "Sector_Spread": 4,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Bank of America Reiterates Buy Rating for Celgene Co.",
            "Correlation": 9,
            "Sentiment": 7,
            "Importance": 7,
            "Impact": 6,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 8,
            "Specificity": 8,
            "Sector_Spread": 3,
            "Tech_Mentions": 1
        },
        {
            "News_content": "$CELG Company Info Updated Sunday, January 31, 2016 00:59:25 AM",
            "Correlation": 8,
            "Sentiment": 6,
            "Importance": 6,
            "Impact": 5,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 7,
            "Specificity": 7,
            "Sector_Spread": 2,
            "Tech_Mentions": 1
        },
        {
            "News_content": "$CELG '15 sales +19.5% on vol driven by Rev/Pomalyst, Otezla, Abraxane. Next up: GED301 in IBD & ozanimod in MS.",
            "Correlation": 10,
            "Sentiment": 8,
            "Importance": 9,
            "Impact": 8,
            "Duration": 7,
            "Virality": 5,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 6,
            "Tech_Mentions": 4
        }
    ]
}